Health TrialsbyHealthPanel

Diabetes Registry Graz for Biomarker Research

ConditionsType1diabetesType 2 DiabetesAdiposity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMedical University of Graz

About this trial

The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 - 99 years

Informed consent has to be given in written form

Type 1 diabetes

Type 2 diabetes

Disqualifiers

No written informed consent

No willingness to participate in this registry

Trial population

Patients with different types of diabetes as well as obesity and lipid metabolism disorder are observed in this registry.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    In this registry no intervention is carried out

Treatment groups

2,000 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Group A: Type 1 Diabetes1 intervention
Group B: Type 2 Diabetes1 intervention
Group C: Adipositas1 intervention
Group D: Lipid metabolism disorder1 intervention
Group E: Type 3 Diabetes Mellitus1 intervention
Group F: Maturity onset diabetes of the young (MODY)1 intervention
Group G: Late onset diabetes of the adult (LADA)1 intervention

Trial outcomes

Primary outcomes

1

Biomarker identification

Identification of biomarker panels that allow prediction of future micro- and macrovascular disease and events. Changes of these biomarkers over time in a selected, defined cohort will be reported.

Time frame
Over entire period of registry (20 years)

Secondary outcomes

1

Biomarker validation

Validation of suggested biomarkers in the field of diabetes complications.

Time frame
Over entire period of registry (20 years)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Medical University of Graz

Lead sponsor

Source ClinicalTrials.gov
Apply now